dilazep has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaochar, S | 1 |
| Rusin, A | 1 |
| Foley, C | 1 |
| Rajapakshe, K | 1 |
| Robertson, M | 1 |
| Skapura, D | 1 |
| Mason, C | 1 |
| Berman De Ruiz, K | 1 |
| Tyryshkin, AM | 1 |
| Deng, J | 1 |
| Shin, JN | 1 |
| Fiskus, W | 1 |
| Dong, J | 1 |
| Huang, S | 1 |
| Navone, NM | 1 |
| Davis, CM | 1 |
| Ehli, EA | 1 |
| Coarfa, C | 1 |
| Mitsiades, N | 1 |
1 other study available for dilazep and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
Inhibition of GATA2 in prostate cancer by a clinically available small molecule.
Topics: Cell Line, Tumor; Chromatin; Dilazep; GATA2 Transcription Factor; Gene Expression Regulation, Neopla | 2021 |